These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 5627947)

  • 41. Simple methods of rabbit hemolytic complement component assays.
    Lindorfer JF; Fong JS; Good RA
    Int Arch Allergy Appl Immunol; 1974; 46(4):539-51. PubMed ID: 4856448
    [No Abstract]   [Full Text] [Related]  

  • 42. The effects of ionic strength, temperature, and antibody class and avidity on fixation and transfer of the first component of complement.
    Linscott WD
    J Immunol; 1969 Apr; 102(4):993-1001. PubMed ID: 5768200
    [No Abstract]   [Full Text] [Related]  

  • 43. Protective effects of various compounds on lysis of antibody-coated sheep erythrocytes by hypotonic shock or complement.
    Müller-Peddinghaus R; Erdtmann K
    Methods Find Exp Clin Pharmacol; 1984 Jun; 6(6):287-92. PubMed ID: 6748820
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Consumption of hamster complement by bacterial endotoxin.
    Hook WA; Snyderman R; Mergenhagen SE
    J Immunol; 1970 Jul; 105(1):268-70. PubMed ID: 5425348
    [No Abstract]   [Full Text] [Related]  

  • 45. [Studies on the terminal hemolysis inducing reaction steps of the complement system].
    Bitter-Suermann D; Hadding U
    Verh Dtsch Ges Pathol; 1970; 54():276-83. PubMed ID: 4104546
    [No Abstract]   [Full Text] [Related]  

  • 46. Kinetics of bovine complement. I. Formation of a lytic intermediate.
    Fong JS; Muschel LH; Good RA
    J Immunol; 1971 Jul; 107(1):28-33. PubMed ID: 5091959
    [No Abstract]   [Full Text] [Related]  

  • 47. Lack of binding of complement by IgD.
    Hiramatsu S; Tsuyuguchi I; Inai S
    Biken J; 1969 Mar; 12(1):43-4. PubMed ID: 4185764
    [No Abstract]   [Full Text] [Related]  

  • 48. The Cl inactivator from guinea pig serum. 3. Characterization and kinetic data of the reaction between the inactivator and EACl and EACl4.
    Loos M; Wolf HU; Opferkuch W
    Immunochemistry; 1972 Apr; 9(4):451-9. PubMed ID: 4113723
    [No Abstract]   [Full Text] [Related]  

  • 49. Blocking of the hemolytic expression of the classical complement sequence by products of complement activation via the alternate pathway. Materials responsible for the blocking phenomenon and their proposed mechanism of action.
    Koethe SM; Austen KF; Gigli I
    J Immunol; 1973 Feb; 110(2):390-400. PubMed ID: 4684033
    [No Abstract]   [Full Text] [Related]  

  • 50. [Effect of complement on the postradiation hemolysis of erythrocytes].
    Ivanov AA; Mozhaĭskiĭ AM
    Radiobiologiia; 1977; 17(4):581-3. PubMed ID: 918283
    [No Abstract]   [Full Text] [Related]  

  • 51. Further evidence for immune cytolysis by antibody and the first eight components of complement in the absence of C9.
    Tamura N; Shimada A; Chang S
    Immunology; 1972 Jan; 22(1):131-40. PubMed ID: 5013908
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Kinetics of bovine complement. II. Properties of the lytic intermediate.
    Fong JS; Muschel LH; Good RA
    J Immunol; 1971 Jul; 107(1):34-40. PubMed ID: 4997115
    [No Abstract]   [Full Text] [Related]  

  • 53. Serum complement and the enzymatic degradation of erythrocyte phospholipid.
    Smith JK; Becker EL
    J Immunol; 1968 Mar; 100(3):459-74. PubMed ID: 5643073
    [No Abstract]   [Full Text] [Related]  

  • 54. Effect of anti-macrophage sera on the in vivo synthesis of guinea pig complement components.
    Füst G; Surján M
    Boll Ist Sieroter Milan; 1971; 50(6):488-94. PubMed ID: 5164108
    [No Abstract]   [Full Text] [Related]  

  • 55. Evidence that rabbit gamma G haemolysin in capable of utilizing guinea-pig complement more efficiently than rabbit gamma M haemolysin.
    Frank MM; Gaither T
    Immunology; 1970 Dec; 19(6):975-81. PubMed ID: 5487544
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Basic study of the erythrocyte antibodies].
    Oikawa K
    Rinsho Byori; 1969 Mar; 17(3):204-9. PubMed ID: 5817178
    [No Abstract]   [Full Text] [Related]  

  • 57. The ninth component of human complement: isolation, description and mode of action.
    Hadding U; Müller-Eberhard HJ
    Immunology; 1969 Jun; 16(6):719-35. PubMed ID: 4182367
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A new immunochemical assay for the detection of the first component of complement C1.
    Colten HR; Spalter JS
    J Immunol; 1970 May; 104(5):1043-7. PubMed ID: 5444335
    [No Abstract]   [Full Text] [Related]  

  • 59. Evidence for restriction of the ability of complement to lyse homologous erythrocytes.
    Houle JJ; Hoffmann EM
    J Immunol; 1984 Sep; 133(3):1444-52. PubMed ID: 6430999
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hemolytic behavior of sheep erythrocytes non-specifically coupled with human Cla.
    Inai S; Tsuyuguchi I
    Biken J; 1969 Mar; 12(1):1-7. PubMed ID: 4980388
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.